Advanced Materials for Biologics Delivery to Brain Tumors
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng +4 more
wiley +1 more source
Factors Associated With Persistent Symptoms Following Mild Traumatic Brain Injury.
Peacock WF +9 more
europepmc +1 more source
Feasibility of an unsupervised aerobic exercise training program for participants with persistent symptoms after SARS-CoV-2 infection. [PDF]
Emmel C +10 more
europepmc +1 more source
Charting Endocrine Progenitors Across Species and Organs
Endocrine progenitors give rise to the hormone‐producing cells of the pancreas and intestine. Using single‐cell multiomics and proteomics, this study compares these progenitors across species, systems, and organs, mapping the conserved and species‐specific gene regulatory networks that guide their formation.
Changying Jing +21 more
wiley +1 more source
Evaluating the efficacy of a personalised sub-symptomatic exercise treatment programme for rehabilitation of military service members with persistent symptoms following mild traumatic brain injury: a randomised controlled trial. [PDF]
Darr AJ +8 more
europepmc +1 more source
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang +6 more
wiley +1 more source
A pilot study of disulfiram for individuals with persistent symptoms despite prior antibiotic treatment for Lyme disease. [PDF]
Kuvaldina M +5 more
europepmc +1 more source
Critical Approach to Hypothyroid Patients With Persistent Symptoms.
Biondi B, Celi FS, McAninch EA.
europepmc +1 more source
. ABSTRACT Neuroinflammation driven by microglial activation is a defining feature of Alzheimer's disease (AD), yet the molecular mechanisms sustaining this proinflammatory state remain unclear. Here, we identify the deubiquitinase OTUD7B as a critical regulator of microglial activation and AD pathology.
Luyao Li +15 more
wiley +1 more source
A double-blind randomized trial of hyperbaric oxygen for persistent symptoms after brain injury. [PDF]
Weaver LK, Ziemnik R, Deru K, Russo AA.
europepmc +1 more source

